Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Beacon Discovery Leverages Partnerships and Elsevier Solutions to Further GCPR R&D Related Research
Posted on April 13th, 2019 by Nicki Catchpole in Pharma R&D
Beacon Discovery is a selected member of Elsevier’s The Hive, which is a partnership engine supporting innovation and R&D with emerging biotech startups. Here, Dr. Carleton Sage explains how leveraging the Elsevier suite of solutions in conjunction with an impassioned approach to GCPR research, Beacon Discovery has made significant strides in the discovery process to solve unmet medical needs.
(more…)Advances in Automated Chemistry Extraction from Patents
Posted on April 3rd, 2019 by Saber A. Akhondi in Pharma R&D
Scholarly research and literature are important elements to inform the beginning stages of R&D efforts. Automated solutions that leverage capabilities such text mining enable researchers to hone in on the most relevant data and inform their research.
(more…)Emulating start-up success with purpose-built data tools
Posted on December 12th, 2018 by Nicki Catchpole in Pharma R&D
Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. (more…)
Small Biotechs Progressing Beyond Startup Status
Posted on November 29th, 2018 by Christy J. Wilson in Pharma R&D
When is a startup no longer a startup? Small biotech companies armed with a talented crop of scientists have been springing up all across the pharma landscape for the last several years, establishing buzzing hubs of innovation. Not all of them find their research efforts successful, but many do and then go on to be acquired by larger pharmaceutical firms that have the resources to bring their ideas to fruition. (more…)
